Ren N.

Ren N. has a diverse work experience spanning several companies and roles. Starting in 2014, Ren worked as an intern in neuropharmacology at Merck, followed by roles as an undergraduate researcher at Harvard Medical School and Massachusetts General Hospital. In 2015, Ren returned to Merck as a genetics and pharmacogenomics intern. Ren then joined Northeastern University as an undergraduate researcher from 2013 to 2017. Ren's industry experience continued with positions at Decibel Therapeutics, where they worked as a genomics and target identification intern, research associate I and II, and as a senior research associate and project manager. From 2020 to 2021, Ren worked as a senior research associate at Rubius Therapeutics, and from 2021 to 2022 as an associate scientist at Cellarity. Most recently, Ren has worked as a consultant at a private company, and as the manager of preclinical research at Solid Biosciences from May 2023. Throughout their career, Ren has gained extensive experience in CRO management, histology/toxicology platform development, and in the management of rodent and non-rodent studies.

Ren N. has attended Northeastern University and Yale University. No start or end years, degree names, or fields of study have been provided for either institution.